Biotech News
Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference
investors.absci.com2026-05-06 15:06 EST
VANCOUVER, Wash. and NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the upcoming 44 th Annual J.P.